Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers.

Celik B, Yalcin AD, Bisgin A, Dimitrakopoulou-Strauss A, Kargi A, Strauss LG.

Med Sci Monit. 2013 Oct 21;19:875-82. doi: 10.12659/MSM.889605.

PMID:
24145180
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Increased serum S-TRAIL level in newly diagnosed stage-IV lung adenocarcinoma but not squamous cell carcinoma is correlated with age and smoking.

Kargi A, Bisgin A, Yalcin AD, Kargi AB, Sahin E, Gumuslu S.

Asian Pac J Cancer Prev. 2013;14(8):4819-22.

PMID:
24083751
[PubMed - indexed for MEDLINE]
Free Article
3.

Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels.

Yalcin AD, Cilli A, Bisgin A, Strauss LG, Herth F.

Expert Opin Biol Ther. 2013 Sep;13(9):1335-41. doi: 10.1517/14712598.2013.819338. Epub 2013 Jul 24.

PMID:
23883435
[PubMed - indexed for MEDLINE]
4.

A case of toxic epidermal necrolysis with diverse etiologies: successful treatment with intravenous immunoglobulin and pulse prednisolone and effects on sTRAIL and sCD200 levels.

Yalcin AD, Karakas AA, Soykam G, Gorczynski RM, Sezer C, Bisgin A, Strauss LG.

Clin Lab. 2013;59(5-6):681-5.

PMID:
23865370
[PubMed - indexed for MEDLINE]
5.

Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma.

Yalcin AD, Bisgin A, Cetinkaya R, Yildirim M, Gorczynski RM.

Clin Lab. 2013;59(1-2):71-7.

PMID:
23505909
[PubMed - indexed for MEDLINE]
6.

Pollen aero allergens and the climate in Mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients.

Yalcin AD, Basaran S, Bisgin A, Polat HH, Gorczynski RM.

Med Sci Monit. 2013 Feb 11;19:102-10.

PMID:
23396359
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

IL-8, IL-10, TGF-β, and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment.

Yalcin AD, Bisgin A, Gorczynski RM.

Mediators Inflamm. 2012;2012:720976. doi: 10.1155/2012/720976. Epub 2012 Dec 19.

PMID:
23316107
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Trimetazidine effect on burn-induced intestinal mucosal injury and kidney damage in rats.

Yalcin AD, Bisgin A, Erbay RH, Oguz O, Demir S, Yilmaz M, Gumuslu S.

Int J Burns Trauma. 2012;2(2):110-7. Epub 2012 Sep 15.

PMID:
23071909
[PubMed]
Free PMC Article
9.

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis.

Yalcin AD, Gumuslu S, Parlak GE, Bısgın A.

Med Sci Monit. 2012 Oct;18(10):CR617-21.

PMID:
23018355
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumab.

Yalcin AD, Bisgin A.

Med Sci Monit. 2012 Aug;18(8):LE9-10. No abstract available.

PMID:
22847211
[PubMed - indexed for MEDLINE]
11.

Jessner lymphocytic infiltrate as a side effect of bee venom immunotherapy.

Yalcin AD, Bisgin A, Akman A, Erdogan G, Ciftcioglu MA, Yegin O.

J Investig Allergol Clin Immunol. 2012;22(4):308-9. No abstract available.

PMID:
22812210
[PubMed - indexed for MEDLINE]
Free Article
12.

Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis.

Yalcin AD, Gumuslu S, Parlak GE, Bisgin A, Yildiz M, Kargi A, Gorczynski RM.

Immunopharmacol Immunotoxicol. 2012 Dec;34(6):1047-53. doi: 10.3109/08923973.2012.697902. Epub 2012 Jun 28.

PMID:
22737977
[PubMed - indexed for MEDLINE]
13.

Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients.

Bisgin A, Yalcin AD, Gorczynski RM.

Diabetes Res Clin Pract. 2012 Jun;96(3):e84-6. doi: 10.1016/j.diabres.2012.02.028. Epub 2012 Mar 23.

PMID:
22446096
[PubMed - indexed for MEDLINE]
14.

Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment.

Yalcin AD, Gorczynski RM, Parlak GE, Kargi A, Bisgin A, Sahin E, Kose S, Gumuslu S.

Clin Lab. 2012;58(1-2):89-96.

PMID:
22372350
[PubMed - indexed for MEDLINE]
15.

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment.

Yalcin AD, Bisgin A, Kargi A, Gorczynski RM.

Med Sci Monit. 2012 Mar;18(3):PI11-5.

PMID:
22367138
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer.

Bisgin A, Kargi A, Yalcin AD, Aydin C, Ekinci D, Savas B, Sanlioglu S.

BMC Cancer. 2012 Feb 7;12:58. doi: 10.1186/1471-2407-12-58.

PMID:
22313795
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Complete gonadal dysgenesis 46,XY (Swyer syndrome) in two sisters and their mother's maternal aunt with a female phenotype.

Bagci G, Bisgin A, Karauzum SB, Trak B, Luleci G.

Fertil Steril. 2011 Apr;95(5):1786.e1-3. doi: 10.1016/j.fertnstert.2010.11.034. Epub 2010 Dec 9.

PMID:
21145048
[PubMed - indexed for MEDLINE]
18.

NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL.

Aydin C, Sanlioglu AD, Bisgin A, Yoldas B, Dertsiz L, Karacay B, Griffith TS, Sanlioglu S.

BMC Cancer. 2010 Oct 27;10:584. doi: 10.1186/1471-2407-10-584.

PMID:
20977779
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

TRAIL death receptor-4, decoy receptor-1 and decoy receptor-2 expression on CD8+ T cells correlate with the disease severity in patients with rheumatoid arthritis.

Bisgin A, Terzioglu E, Aydin C, Yoldas B, Yazisiz V, Balci N, Bagci H, Gorczynski RM, Akdis CA, Sanlioglu S.

BMC Musculoskelet Disord. 2010 Aug 27;11:192. doi: 10.1186/1471-2474-11-192.

PMID:
20799941
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis.

Terzioglu E, Bisgin A, Sanlioglu AD, Ulker M, Yazisiz V, Tuzuner S, Sanlioglu S.

Rheumatology (Oxford). 2007 May;46(5):783-9. Epub 2007 Feb 19.

PMID:
17309888
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk